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Serotype changes among natural isolates of Streptococcus pneumoniae are well documented and occur by
recombinational exchanges at the capsular biosynthetic locus. However, the frequency with which this phe-
nomenon occurs within the nasopharynx of children is not clear and is likely to be highest in the nasopharynx
of children, who have high rates of pneumococcal carriage. A birth cohort of 100 infants was studied, and
pneumococci were recovered from nasopharyngeal samples taken at monthly intervals during the first 6
months of life and then at 2-monthly intervals until the age of 2 years. Among the 1,353 nasopharyngeal
samples were 523 that contained presumptive pneumococci, and three colonies from each were serotyped. A
total of 333 isolates, including all isolates of differing serotypes from the same child, were characterized by
multilocus sequence typing. Sixty-eight children carried multiple serotypes during the first 2 years of life. Two
children carried a typeable and a nonserotypeable pneumococcus of identical genotype, and five children
carried genetically indistinguishable isolates of serotypes 15B and 15C. These isolates were considered,
respectively, to be due to loss of capsule expression and the known ability of serotype 15B and 15C pneumococci
to interconvert by loss or gain of an acetyl group on the capsular polysaccharide. In all other cases, isolates
from the same children that differed in serotype also differed in genotype, indicating the acquisition of a
different pneumococcal strain rather than a change in capsular type. There was therefore no evidence in this
study for any change of serotype due to recombinational replacements at the capsular locus among the
pneumococci carried within the nasopharynges of the children.
Streptococcus pneumoniae causes diseases that range in se-
verity from acute otitis media and sinusitis to pneumonia,
septicemia, and meningitis (1, 14). Pneumococcal disease is
considered to occur subsequent to nasopharyngeal coloniza-
tion, which typically occurs soon after birth (10, 14). Carriage
is a highly dynamic process, with pneumococci being acquired,
carried for a period of weeks or months, and then lost (10). A
subset of the 90 pneumococcal serotypes are commonly car-
ried by children, and these isolates also are the major causes of
disease in children (11). Multivalent conjugate capsular poly-
saccharide vaccines have been developed to protect infants
from pneumococcal disease caused by these common child-
hood serotypes, and in clinical trials these have proved effec-
tive in preventing invasive disease by the vaccine serotypes (3).
In almost all of the clinical trials a reduction in carriage of
the vaccine serotypes and an increase in carriage of nonvaccine
serotypes have been observed among vaccinated children (7,
12, 14). The extent, duration, and clinical significance of this
serotype replacement are unclear (12, 16a). Isolates of the
nonvaccine serotypes are considered to be less virulent than
those of the vaccine serotypes, and thus even if vaccine sero-
types are replaced with a new set of nonvaccine serotypes after
mass vaccination, it is considered likely that a large reduction
in the prevalence of invasive pneumococcal disease will be
maintained (12, 16a). The effect of replacement may be more
significant in acute otitis media since in the Finnish efficacy
trials of seven-valent conjugate pneumococcal vaccines, sero-
type replacement led to a significant increase in otitis media
caused by nonvaccine serotypes (9).
One consequence of serotype replacement following mass
vaccination is the increased selective pressure for emergence
of penicillin resistance and multiple antibiotic resistance
among those nonvaccine serotypes that become more preva-
lent in the nasopharynges of children (16a). At present almost
all of the major antibiotic-resistant clones of S. pneumoniae are
of vaccine serotypes or serotypes for which the vaccines should
provide cross-protection—notably, serotypes 6B, 6A, 9V, 14,
19F, 19A, and 23F (12). Resistance to penicillin is difficult to
achieve de novo, but resistance to penicillin and to other
classes of antibiotics can occur in a new serotype, in a single
step, by a change of serotype within one of the highly successful
international multiply antibiotic-resistant clones (16a). Evi-
dence that pneumococci can change their serotype in vivo was
first obtained from the analysis of populations of antibiotic-
resistant pneumococci, in which isolates were identified that
were indistinguishable in genotype but that differed in serotype
(4). Subsequently, there have been numerous reports of sero-
type variants of the major penicillin-resistant and multiply an-
tibiotic-resistant clones (13), and molecular studies have shown
that these serotype changes occur by recombinational events
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that replace the capsular biosynthetic genes of a recipient
pneumococcus with the corresponding genes from a donor
pneumococcus of a different serotype (5, 6). Almost all re-
ported examples of serotype changes have been from one vac-
cine serotype to another vaccine serotype, presumably because
these are the serotypes most commonly present to act as do-
nors and recipients of capsular genes within the nasopharynx
of children. Serotype replacement after mass vaccination
would lead to more donors of capsular genes of nonvaccine
serotypes in the nasopharynx, which, combined with selection
favoring both the emergence of antibiotic resistance and of
nonvaccine serotypes, could lead to the appearance of variants
of the successful major antibiotic-resistant clones with nonva-
ccine serotypes (16a).
Although there is ample evidence for the occurrence of
serotype changes, there is very little information about the
frequency of these events during colonization of the nasophar-
ynx. In this study, nasopharyngeal swabs were taken at 15
sampling points, between 1 month and 2 years of age, from a
birth cohort of 100 children. Children who carried at least two
pneumococci of differing serotype during the first 2 years of life
were identified, and molecular characterization of 333 isolates
from these children was carried out using multilocus sequence
typing (MLST) (8). There was no evidence in these children
for any changes of serotype mediated by recombinational re-
placements at the capsular locus during nasopharyngeal car-
riage.
MATERIALS AND METHODS
Identification and microbiological characterization of pneumococcal isolates.
Study isolates were obtained from a longitudinal pneumococcal carriage study
performed by the Oxford Vaccine Group (University of Oxford) during the
period from 1999 to 2001. Children were enrolled in this study at birth and lived
throughout the city of Oxford, United Kingdom, or in the surroundings of
Oxford. Samples of the nasopharyngeal flora were obtained from 100 children
using cotton-tipped swabs, which were streaked onto sheep blood-gentamicin
agar. Three alpha-hemolytic colonies from the primary agar plate were isolated
in an attempt to recognize some of the children who were colonized with mul-
tiple strains of pneumococci. Identification of organisms as S. pneumoniae was
performed using standard microbiological methods: colony morphology, bile
solubility, and Optochin susceptibility. Serotyping was performed using the Quel-
lung reaction with sera purchased from the Statens Serum Institut, Copenhagen,
Denmark. Isolates that were nonserotypeable but Optochin susceptible and bile
soluble were considered to be presumptive pneumococci. The presence of the
pneumolysin gene in these isolates was examined using PCR (15). As described
below, MLST resolved these isolates into those that appeared to be pneumococci
that failed to express a capsule, and into isolates that were similar to, but distinct
from, pneumococci. A similar phylogenetic distinction has been made by What-
more et al., who showed that both of these groups of isolates possess the
pneumolysin gene (18).
Molecular characterization of pneumococcal isolates. Pneumococcal isolates,
and the nonserotypeable presumptive pneumococci, were unambiguously char-
acterized by MLST as described by Enright and Spratt (8). The sequences
(alleles) at each locus were compared to those at the MLST website (www.mlst
.net) and were assigned allele numbers if they corresponded to sequences already
submitted to the pneumococcal MLST database; novel sequences were assigned
new allele numbers and were deposited in the database. The allelic profiles of
isolates (the allele numbers at the seven loci) were compared to those at the
MLST website, and sequence types (STs) were assigned. Allelic profiles that
were not represented in the MLST database were assigned new ST numbers and
were deposited in the database. The similarities between the STs were shown by
cluster analysis, using the matrix of pairwise differences between the allelic
profiles of all isolates, and the unweighted pair-group method with arithmetic
averages.
RESULTS
Sampling and selection of carried pneumococci for molec-
ular characterization. The carriage study was designed to sam-
ple the nasopharynges of 100 children, living in Oxford or the
surrounding region, at 15 sampling points from 1 month to 2
years of age. Of these, 21 children were not sampled for the
whole 2-year period, and for 2 others 1 of the 15 samples was
not obtained, but 1,353 of the anticipated 1,500 swabs were
available for analysis. Almost all children were colonized dur-
ing the first 2 years of life. Of the 100 children, there were only
8 who appeared not to be colonized by a pneumococcus during
this period, but 7 of these were children who withdrew from
the study before the end of the 2 years. Presumptive pneumo-
cocci were present in 523 of the 1,353 nasopharyngeal samples
from the 92 children in which colonization was detected, and
three colonies from each positive nasopharyngeal sample were
serotyped. Pneumococci of only a single serotype were identi-
fied in 18 of these children during the 2-year period. For the
other 74 colonized children, two or more pneumococcal iso-
lates of different serotypes (or a serotypeable pneumococcus
and a nonserotypeable presumptive pneumococcus) were ob-
tained from the nasopharyngeal samples.
A total of 333 carried isolates from the 74 children were
characterized by MLST. Isolates were selected for character-
ization by MLST if they were of a serotype different from that
of any of the isolates obtained in the previous positive sample
from the child (even if isolates of that serotype had been
previously recovered in an earlier sample), or where there were
isolates of differing serotype in the same sample. Table 1 shows
the pneumococci isolated from two of the children and those
selected for characterization by MLST using the above criteria.
Characterization of nonserotypeable isolates. There were 31
nonserotypeable presumptive pneumococci among the 333 iso-
lates, all of which tested positive for the pneumolysin gene
using PCR. Four of these possessed alleles at six or all seven of
the MLST loci that were found in serotypeable pneumococci
within the MLST database. Two of these four isolates were
identical in ST to serotypeable isolates from the same children,
and isolates with an identical ST and serotype were also
TABLE 1. Selection of isolates for molecular characterization
Mo of
sampling
Child 2 Child 28
Serotype Serotype selectedfor MLST Serotype
Serotype selected
for MLST
1 21 19A
2 21 19A
3 21
4 21 19A 19A
5 21 11A 11A
6 21
8 21 21 14 14
10 19F 19F 21 21
12 8  14 8  14 6A 6A
14 22F 22F 6B 6B
16 6B
18
20 6A 6A
22 6A
24 23A 23A 6A 6A
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present within the MLST database. The other two isolates each
had six alleles that were found in serotypeable pneumococci
within the MLST database, although their allelic profiles were
not closely similar to any serotypeable isolates in the MLST
database. These four isolates were therefore assigned as pneu-
mococci that were not expressing capsular polysaccharide. The
other 27 nonserotypeable isolates had alleles at six or all seven
loci that were not found in any serotypeable pneumococci.
Furthermore, as these novel alleles were several percent diver-
gent from the alleles found in serotypeable pneumococci, they
were not considered to be pneumococci and were not used in
the further analyses.
Characterization of pneumococci from longitudinal car-
riage. The remaining 306 pneumococcal isolates were resolved
by MLST into 101 STs. Children often carried the same ST
over several sampling points, and 235 pneumococcal isolates
remained when multiple isolates of the same strain from the
same child were removed. The serotype distribution and ge-
netic relatedness of these 235 isolates were studied, as this
subset indicates the prevalence of the serotypes and STs car-
ried by the children. Serotypes 6B, 19F, 23F, 14, and 6A were
the five most commonly carried serotypes, together represent-
ing 56% of all carried isolates (Table 2).
The genotypes of the carried isolates were very diverse and
64 of the 101 STs were recovered from only a single child; the
other 37 STs colonized between 2 and 18 children. Table 3
shows the properties of the pneumococcal STs that were re-
covered from more than one child. Figure 1 displays the sim-
ilarities between the genotypes of the 235 isolates as a dendro-
gram which shows there were three major clusters of closely
related STs (clonal complexes). Together these three clonal
complexes included 81 of the 235 carriage isolates (35%).
Following the removal of the 27 nonserotypeable isolates
that were not considered to be pneumococci, there were 68
children who carried at least two pneumococci of differing
serotype, and 229 isolates from these children remained when
multiple isolates of the same strain from the same child were
removed. Examination of the pneumococci from the 68 chil-
dren showed that, in almost all cases, isolates of different
serotypes from the same child were also different in ST. Table
4 provides details of the isolates from the 14 children who over
the 2 years carried isolates of multiple serotypes and from
which at least seven pneumococci were selected for character-
ization by MLST, according to the criteria described above.
Details of the pneumococci carried by all of the 68 children are
available from the authors on request.
There were a few examples of isolates of the same ST, from
the same child, that differed in serotype. Five children carried
isolates of the same ST that were either serotype 15B or 15C
(e.g., child 25 [Table 4]), and two children carried isolates of
the same ST that were serotypeable and nonserotypeable. In
one of these children, serotype 18C and nonserotypeable iso-
lates with the same allelic profile (ST113) were recovered in
the 2-month sample, and an identical serotype 18C isolate was
also recovered at the 5-month sampling. In the other child a
serotype 14 isolate (ST9) was present at the 12-month sam-
pling, and an identical isolate that was nonserotypeable was
recovered at the 16-month sampling.
DISCUSSION
A total of 333 serotypeable or nonserotypeable presumptive
pneumococci were characterized by MLST. Thirty-one of the
isolates were nonserotypeable. The large majority (87%) of
these nonserotypeable presumptive pneumococci were not
considered to be pneumococci, whereas others were assigned
as pneumococci that did not express capsular polysaccharide.
MLST provides a clear way of distinguishing these two classes
of nonserotypeable isolates. Isolates with alleles at all or most
loci that are found in serotypeable pneumococci, or that have
unique alleles which differ at only two or three nucleotides
from a known pneumococcal allele, are assigned as pneumo-
cocci. Those that have alleles at all or most loci that are not
found in serotypeable pneumococci, and which are several
percent diverged in sequence from pneumococcal alleles, are
assigned as isolates that are similar to, but distinct from, pneu-
mococci. The identification among nonserotypeable presump-
tive pneumococci of both pneumococci that do not express a
capsule and isolates very closely related to, but genetically
distinct from, pneumococci has also been shown using molec-
ular techniques by Whatmore et al. (18). As found by these
authors, the latter class of isolates all possessed the pneumo-
TABLE 2. Serotype distribution and diversity of
carried pneumococcal isolates
Serotype(s) No. of isolates No. of STsa
6B 44 11
19F 30 16
23F 26 6
14 17 5
6A 14 7
15B, 15Cb 12 4
19A 9 6
9V 8 4
18C 7 2
3 6 1
21 5 5
9N 5 2
11A 5 2
23A 4 4
8 4 2
22F 4 2
33F 4 2
17F 4 1
16F 3 3
20 3 2
38 3 2
15A 2 2
10A 2 1
12F 2 1
24F 2 1
4 1 1
7F 1 1
13 1 1
23B 1 1
27 1 1
31 1 1
35F 1 1
37 1 1
NTc 2 2
a The total number of STs is greater than 101 as isolates of some STs were of
differing serotype.
b Isolates of serotypes 15B and 15C were considered together (see text).
c NT, nonserotypeable.
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lysin gene, which is not a totally reliable indicator that an
isolate is a pneumococcus, as besides being present in the latter
isolates, the gene is present (and expressed) in some more
distantly related isolates that are more closely allied to Strep-
tococcus mitis than to S. pneumoniae (18).
The isolates carried by the children were of 33 different
serotypes, although isolates of the common childhood sero-
types predominated. As found previously for pneumococci
from invasive disease (8), multiple STs are represented within
most serotypes of carried pneumococci. The STs that were
commonly carried typically corresponded to STs that have also
been recovered from cases of invasive disease. Isolates from
invasive disease were present in the MLST database for 12 of
the 16 STs carried by at least four children. This report focuses
on serotype changes during carriage, and a comparison of the
carried and invasive isolates from age-matched children in the
Oxford region will be reported elsewhere.
The vast majority of isolates with different serotypes ob-
tained from the same child had different STs and were there-
fore genetically distinct. In most cases, the appearance of an
isolate with a different serotype from that which was previously
carried was thus due to the acquisition of a new pneumococcal
strain, rather than to a change in the serotype of the resident
strain. There were a few exceptions which need to be consid-
ered. Five children carried isolates of serotypes 15B and 15C
that had the same ST, and two children carried a serotypeable
and a nonserotypeable isolate of the same ST. The capsular
polysaccharides of serotypes 15B and 15C differ only in the
presence or absence of an acetyl group, and these serotypes are
known to interconvert in vitro and in vivo, by an unknown
molecular mechanism, at a low frequency (17). The isolation of
genetically indistinguishable serotype 15B and 15C pneumo-
cocci from the same children is therefore considered to be a
reflection of this interconversion process rather than a change
of capsular serotype mediated by recombinational replace-
ments at the capsular locus. Similarly, the interconversion
from serotypeable to nonserotypeable presumably reflects a
loss of capsular expression rather than a true change of
serotype.
There were therefore no examples of changes of serotype
TABLE 3. Properties of pneumococci carried by more than one child
ST Serotype(s)a No. ofchildren
Allele at MLST locusb:
Comment
aroE gdh gki recP spi xpt ddl
138 6A(1)/6B 18 7 5 8 5 10 6 14
36 23F 13 1 8 4 1 1 4 6
162 9V(5)/19F 12 7 11 10 1 6 8 14
176 6B 9 7 13 8 6 10 6 14
311 23F 9 1 8 9 1 6 4 6
65 6A 8 2 7 4 10 10 1 27
9 14 8 1 5 4 5 5 1 8 England14-9 clone
402 6B 7 7 1 8 6 10 6 14
199 15B(3)/15C 7 8 13 14 4 17 4 14
180 3 6 7 15 2 10 6 1 22
124 14 6 7 5 1 8 14 11 14
113 18C 5 7 2 1 1 10 1 21
66 9N 4 2 8 2 4 6 1 1
62 11A 4 2 5 29 12 16 3 14
392 17F 4 7 5 1 1 6 31 14
422 19F 4 18 9 4 18 15 1 14
53 8 3 2 5 1 11 16 3 14
411 15B(1)/15C 3 2 13 14 4 17 4 14
415 19A 3 1 5 12 5 14 15 31
433 22F 3 1 1 4 1 18 58 17
60 33F 3 2 5 23 18 10 3 1
146 6B 2 7 6 1 2 6 15 14
273 6B 2 5 6 1 2 6 1 14
400 6B 2 7 5 8 5 57 6 14
156 9V/14 2 7 11 10 1 6 8 1 Spain9V-3 clone
97 10A 2 5 7 4 2 10 1 27
218 12F 2 10 20 14 1 6 1 29
121 18C 2 7 2 25 1 10 1 21
416 19A 2 1 13 14 4 17 51 14
420 19F 2 15 38 19 5 36 20 6
421 19F 2 3 10 2 5 9 48 6
423 19F 2 1 5 4 12 5 3 8
424 19F 2 1 5 4 5 9 3 8
177 19F 2 7 14 4 12 1 1 14
235 20 2 15 8 8 18 15 1 31
72 24F 2 2 13 2 4 9 4 1
393 38 2 10 43 41 18 13 49 6
a Number of isolates of the minority serotype in parentheses.
b aroE, gene encoding shikimate dehydrogenase; gdh, gene encoding glucose-6-phosphate dehydrogenase; gki, gene encoding glucose kinase; spi, gene encoding signal
peptidase I; xpt, gene encoding xanthine phosphotransferase; ddl, gene encoding D-ala-D-ala ligase.
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mediated by recombinational events at the capsular locus
among the pneumococcal isolates recovered from sequential
samplings of the nasopharynx in this cohort of children. These
results put some limits on the frequency of serotype changes
during nasopharyngeal carriage and suggest that the phenom-
enon is relatively rare. Single examples of putative serotype
changes during nasopharyngeal colonization have been re-
ported in two previous studies. One involved a child in a day
care center who initially carried a multiresistant serotype 23F
isolate and subsequently carried an isolate of serotype 14 that
was shown to be similar by pulsed-field gel electrophoresis (2).
The other was a longitudinal study of carriage in a birth cohort
of 19 children (16). In the latter study there were only 10
children who carried pneumococci of more than one serotype,
and using the selection criteria used here (Table 1) there were
26 isolates of differing serotype obtained from these children,
compared with 68 children and 229 isolates of differing sero-
type in our study. It is not clear why serotype changes were
apparently found in these previous studies but were not found
in our considerably larger study.
Serotype changes are well documented from the presence
among pneumococcal populations of isolates of the same ST
with different serotypes, and although there were no examples
of serotype changes in individual children, there were several
examples among the population of carried pneumococci stud-
ied here. Excluding the two STs that included isolates of both
serotypes 15B and 15C, which are not considered to be due to
a recombinational change of serotype, there were three STs
that included isolates of two different serotypes (Table 3). One
of these was ST156, a widely disseminated penicillin-resistant
clone (Spain9V-3 [13]), isolates of which are usually serotype
9V, but (as in this study) serotype 14 isolates also are encoun-
tered (6).
The sequences of the capsular genes of different serotype 14
variants of the Spain9V-3 clone, and of serotype 19A and 19F
variants of the multiresistant Spain23F-1 clone, have demon-
strated that each of these three classes of serotype variants has
arisen on multiple occasions by recombinational events at the
capsular locus (5, 6; T. J. Coffey and B. G. Spratt, unpublished
results). Although serotype changes appear to be relatively
common, on the basis of both the analysis of pneumococcal
populations and the multiple origins of the serotype variants of
the major antibiotic-resistant clones, these events are not so
common that they can readily be observed by monitoring the
pneumococci carried over time by a cohort of children. This
does not imply that these events are insignificant in the evolu-
tion of the pneumococcus, since isolates that do undergo a
change of serotype may on occasion increase in frequency
within the nasopharynx, either by chance or by selection favor-
ing the variant serotype, providing the possibility of transmis-
sion to new hosts. Whether serotype changes are of any great
consequence is unclear, but the possibility of selection (for
both antibiotic resistance and the nonvaccine serotype) leading
to the emergence in vaccinated populations of nonvaccine se-
FIG. 1. Relatedness of isolates from the nasopharynges of children. The 235 isolates that represent the diverse strains recovered from the
children were analyzed by MLST, and their relatedness was displayed as a dendrogram. ST numbers are shown for those STs recovered from more
than four children. The node that defines each of three major clonal complexes within the carriage population is indicated with an asterisk. The
serotype 6B clonal complex included 36 isolates of type 6B, 1 isolate of type 6A, and 1 isolate of type 23F. The serotype 23F clonal complex included
25 isolates, all of type 23F, and the 19F/9V complex included 10 isolates of serotype 19F, 7 isolates of type 9V, and 1 isolate of type 14.
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TABLE 4. Isolates from children carrying more than six pneumococcal isolates
Isolatea Sero-type
Allele at MLST locusb:
ST Isolatea Sero-type
Allele at MLST locusb:
ST
aroE gdh gki recP spi xpt ddl aroE gdh gki recP spi xpt ddl
2-8.21 21 10 8 4 35 6 1 18 429
2-10.19F 19F 15 38 19 5 36 20 6 420
2-12.8 8 2 5 1 11 16 3 14 53
2-12.14 14 1 5 4 5 5 1 8 9
2-14.22F 22F 1 1 4 1 18 58 17 433
2-20.6A 6A 1 5 7 12 10 1 14 327
2-24.23A 23A 1 51 9 2 6 4 6 435
5-6.6B 6B 5 6 1 2 6 1 14 273
5-10.23F 23F 1 8 9 1 6 4 6 311
5-12.18C 18C 7 2 1 1 10 1 21 113
5-12.23F 23F 1 8 9 1 6 4 6 311
5-16.19F 19F 3 10 2 5 9 48 6 421
5-18.6B 6B 5 6 1 2 6 3 4 90
5-20.19F 19F 3 10 2 5 9 48 6 421
5-20.6B 6B 5 6 1 2 6 3 4 90
5-24.3 3 7 15 2 10 6 1 22 180
5-24.6B 6B 5 6 1 2 6 3 4 90
5-24.19F 19F 3 10 2 5 9 48 6 421
25-6.NT NTc 8 5 2 27 2 11 71 448
25-12.15B 15B 8 13 14 4 17 4 14 199
25-12.15C 15C 8 13 14 4 17 4 14 199
25-14.15B 15B 8 13 14 4 17 4 14 199
25-14.15C 15C 8 13 14 4 17 4 14 199
25-14.NT NT 8 37 9 29 2 47 5 449
25-16.19A 19A 1 5 12 5 14 15 31 415
28-4.19A 19A 10 13 14 4 17 95 14 450
28-5.11A 11A 2 5 29 12 16 3 14 62
28-8.14 14 8 5 4 5 1 3 8 409
28-10.21 21 10 8 4 35 6 1 14 432
28-12.6A 6A 2 7 4 10 10 1 27 65
28-14.6B 6B 7 5 8 5 10 6 14 138
28-24.6A 6A 2 7 4 10 10 1 27 65
32-5.19F 19F 7 11 10 6 6 8 14 165
32-6.19F 19F 7 11 10 6 6 8 14 165
32-8.14 14 1 5 4 5 5 1 8 9
32-10.6A 6A 2 7 4 10 10 1 27 65
32-12.6A 6A 2 7 4 10 10 1 27 65
32-12.19F 19F 7 11 10 6 6 8 14 165
32-14.6A 6A 2 7 4 10 10 1 27 65
32-16.19F 19F 7 11 10 6 6 8 14 165
32-20.11A 11A 2 5 29 12 16 3 14 62
32-22.11A 11A 2 5 29 12 16 3 14 62
32-24.23F 23F 1 8 4 1 1 4 6 36
38-10.6B 6B 7 5 8 5 10 6 14 138
38-14.23F 23F 7 5 1 1 13 31 14 440
38-20.6B 6B 7 5 8 5 10 6 14 138
38-20.23F 23F 7 13 8 6 10 6 69 441
38-22.23F 23F 1 8 4 1 1 4 6 36
38-24.3 3 7 15 2 10 6 1 22 180
38-24.6B 6B 7 5 8 5 10 6 14 138
44-4.19F 19F 18 9 4 18 15 1 14 422
44-6.19F 19F 18 9 4 18 15 1 14 422
44-12.23B 23B 1 8 9 2 6 4 6 439
44-14.6A 6A 2 7 4 10 10 1 27 65
44-14.19F 19F 18 9 4 18 15 1 14 422
44-16.6B 6B 7 5 8 5 57 6 14 400
44-22.19F 19F 18 9 4 18 15 1 14 422
44-24.6B 6B 7 6 1 2 6 71 14 401
a Isolates are named as follows: child identification number-month sampled after birth.serotype.
b See footnote b of Table 3 for explanation of genes.
c NT, nonserotypeable.
47-5.38 38 1 43 41 18 13 49 6 310
47-6.18C 18C 7 2 1 1 10 1 21 113
47-8.19F 19F 18 9 4 18 15 1 14 422
47-10.19F 19F 18 9 4 18 15 1 14 422
47-12.18C 18C 7 2 1 1 10 1 21 113
47-14.9N 9N 2 8 2 4 6 1 1 66
47-24.6B 6B 7 5 8 5 57 6 14 400
52-4.19F 19F 1 5 4 12 5 3 8 423
52-5.19F 19F 1 5 4 12 5 3 8 423
52-6.19F 19F 1 5 4 12 5 3 8 423
52-10.14 14 7 11 10 1 6 8 1 156
52-10.19F 19F 1 5 4 12 5 3 8 423
52-12.14 14 7 11 10 1 6 8 1 156
52-14.14 14 7 11 10 1 6 8 1 156
52-18.6B 6B 7 5 8 5 10 6 14 138
52-22.6B 6B 7 5 8 5 10 6 14 138
53-10.6B 6B 7 6 1 2 6 15 14 146
53-14.6A 6A 2 7 4 10 10 1 27 65
53-16.15B 15B 8 13 14 4 17 4 14 199
53-18.19A 19A 1 5 12 5 14 15 31 415
53-22.9V 9V 7 11 10 1 6 8 14 162
53-22.22F 22F 1 1 4 1 18 58 17 433
53-24.33F 33F 2 5 29 5 42 3 18 445
58-6.19F 19F 18 9 4 18 15 1 14 422
58-8.14 14 1 5 4 5 5 1 8 9
58-10.19F 19F 18 9 4 18 15 1 14 422
58-12.6B 6B 7 1 8 6 10 6 14 402
58-12.19F 19F 18 9 4 18 15 1 14 422
58-16.6B 6B 7 13 8 6 10 54 14 403
58-18.6B 6B 7 13 8 6 10 54 14 403
58-22.6A 6A 2 7 4 10 10 1 27 65
58-24.6A 6A 2 7 4 10 10 1 27 65
58-24.6B 6B 7 13 8 6 10 54 14 403
74-6.3 3 7 15 2 10 6 1 22 180
74-12.9N 9N 10 20 2 1 6 1 29 405
74-14.9N 9N 10 20 2 1 6 1 29 405
74-14.27 27 8 17 46 24 9 55 14 443
74-16.21 21 8 10 2 16 1 26 1 193
74-18.15B 15B 2 13 14 4 17 4 14 411
74-20.19A 19A 1 5 12 5 14 15 32 418
81-4.23A 23A 1 5 9 9 6 4 6 438
81-6.19F 19F 1 10 4 1 9 3 8 43
81-10.23A 23A 1 5 9 9 6 4 6 438
81-12.23A 23A 1 5 9 9 6 4 6 438
81-16.19F 19F 1 10 4 1 9 3 8 43
81-18.19F 19F 1 10 4 1 9 3 8 43
81-18.6B 6B 5 6 1 2 6 1 14 273
81-22.6B 6B 5 6 1 2 6 1 14 273
98-12.15A 15A 8 10 2 16 7 26 1 410
98-16.6B 6B 7 5 8 5 10 6 14 138
98-20.6B 6B 7 5 8 5 10 6 14 138
98-20.19F 19F 1 5 1 15 9 28 8 427
98-22.9V 9V 7 11 10 1 6 73 14 407
98-22.19F 19F 1 5 1 15 9 28 8 427
98-24.19F 19F 1 5 1 15 9 28 8 427
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rotype variants of the successful antibiotic-resistant clones
needs to be monitored, as transmission of these among chil-
dren could limit the expected reduction in antibiotic resistance
among isolates causing pneumococcal disease.
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